[1]刘立友,吴东洋,蔡青山,等.原发性肝癌组织中层粘连蛋白3、黏着斑激酶蛋白表达及其与患者临床病理特征和预后关系研究[J].陕西医学杂志,2023,52(9):1259-1263.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.034]
　LIU Liyou,WU Dongyang,CAI Qingshan,et al.Expression of LAMA3 and FAK proteins in primary liver cancer and their relationship with clinicopathological features and prognosis of patients[J].,2023,52(9):1259-1263.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.034]
点击复制

原发性肝癌组织中层粘连蛋白3、黏着斑激酶蛋白表达及其与患者临床病理特征和预后关系研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年9期
页码:
1259-1263
栏目:
临床病理
出版日期:
2023-09-05

文章信息/Info

Title:
Expression of LAMA3 and FAK proteins in primary liver cancer and their relationship with clinicopathological features and prognosis of patients
作者:
刘立友; 吴东洋; 蔡青山; 郑建兴; 李树栋; 刘 东
(唐山中心医院肝胆外科,河北 唐山 063000)
Author(s):
LIU Liyou; WU Dongyang; CAI Qingshan; ZHENG Jianxing; LI Shudong; LIU Dong
(Department of Hepatobiliary Surgery,Tangshan Central Hospital,Tangshan 063000,China)
关键词:
原发性肝癌;  层粘连蛋白3;  黏着斑激酶;  临床病理特征;  淋巴结转移;  血管侵犯;  预后
Keywords:
Primary liver cancer;  Laminin 3;  Focal adhesion kinase;  Clinicopathologic features;  Lymph node metastasis;  Vascular invasion;  Prognosis
分类号:
R 735.7
DOI:
DOI:10.3969/j.issn.1000-7377.2023.09.034
文献标志码:
A
摘要:
目的:探讨层粘连蛋白3(LAMA3)、黏着斑激酶(FAK)蛋白在原发性肝癌组织中的表达情况,分析它们与患者临床病理特征和预后的关系。方法:选取接受手术治疗的原发性肝癌患者75例,收集癌组织和癌旁组织标本。采用免疫组化染色检测癌组织和癌旁组织LAMA3、FAK蛋白表达。术后随访肝癌患者3年,统计生存情况。分析肝癌组织LAMA3、FAK蛋白表达与患者临床病理特征的关系。采用Kaplan-Meier生存曲线分析LAMA3、FAK蛋白表达与原发性肝癌患者预后的关系。采用Logistic回归分析原发性肝癌患者预后的影响因素。结果:肝癌组织LAMA3和FAK蛋白阳性表达率高于癌旁组织LAMA3和FAK蛋白阳性表达率(均P<0.05)。有淋巴结转移和血管侵犯的患者肝癌组织LAMA3、FAK蛋白阳性表达率高于无淋巴结转移和无血管侵犯的患者(均P<0.05)。术后随访3年,生存患者35例,病死患者40例。Kaplan-Meier生存曲线分析显示,肝癌组织LAMA3、FAK蛋白表达阳性患者3年累积生存率低于LAMA3、FAK蛋白表达阴性患者(均P<0.05)。Logistic回归分析发现,有淋巴结转移、有血管侵犯、LAMA3蛋白阳性和FAK蛋白阳性是原发性肝癌患者术后3年预后的独立危险因素(均P<0.05)。结论:原发性肝癌组织中LAMA3、FAK蛋白呈高表达,且两者阳性表达与患者淋巴结转移、血管侵犯及预后有关,可能作为原发性肝癌潜在的预后标志物。
Abstract:
Objective:To investigate the expression of laminin 3(LAMA3)and focal adhesion kinase(FAK)proteins in primary liver cancer tissues,and to analyze their relationship with clinicopathologic features and prognosis of patients.Methods:Seventy-five patients with primary liver cancer undergoing liver cancer resection were selected,and the cancer tissue and paracancerous tissue specimens were collected.Immunohistochemical staining was used to detect the expression of LAMA3 and FAK proteins in cancer tissues and paracancerous tissues.Patients were followed up for 3 years to calculate their survival status.The relationship between the expression of LAMA3,FAK proteins in cancer tissues and clinicopathological characteristics was analyzed.Kaplan-Meier survival curve was used to analyze the relationship between the expression of LAMA3,FAK proteins and the prognosis of patients with primary liver cancer.Logistic regression analysis was used to analyze the prognostic influencing factors of patients with primary liver cancer.Results:The positive expression rates of LAMA3 and FAK proteins in liver cancer tissues were higher than those in adjacent tissues(both P<0.05).The positive expression rates of LAMA3 and FAK proteins in liver cancer tissues of patients with lymph node metastasis and vascular invasion were higher than those of patients without lymph node metastasis and vascular invasion(both P<0.05).After 3 years of follow-up,35 patients survived and 40 patients died.Kaplan-Meier survival curve analysis showed that the 3-year cumulative survival rate of patients with positive LAMA3 and FAK proteins expression in liver cancer tissues was lower than that of patients with negative LAMA3 and FAK proteins expression(both P<0.05).Logistic regression analysis showed that lymph node metastasis,vascular invasion,LAMA3 protein positive and FAK protein positive were independent risk factors for the 3-year prognosis of patients with primary liver cancer(all P<0.05).Conclusion:LAMA3 and FAK proteins are highly expressed in primary liver cancer tissues,and their positive expressions are related to lymph node metastasis,vascular invasion and prognosis of patients,which may be used as potential prognostic markers for primary liver cancer.

参考文献/References:

[1] 赵培西,许建秦,袁 彬,等.扶正抗癌方治疗肝癌肝郁脾虚瘀毒证临床研究[J].陕西中医,2022,43(12):1746-1748.
[2] 陶 琳.原发性肝癌患者化疗后抗菌药物的应用及继发感染的危险因素分析[J].陕西医学杂志,2023,52(1):89-92.
[3] Shu C,Wang W,Wu L,et al.LINC00936/microRNA-221-3p regulates tumor progression in ovarian cancer by interacting with LAMA3[J].Recent Pat Anticancer Drug Discov,2023,18(1):66-79.
[4] 段绍毅,王君辅,邱 越,等.Lumican调控FAK信号通路对胃癌AGS细胞增殖、侵袭和迁移的影响[J].广西医科大学学报,2021,38(4):676-681.
[5] Ma B,Ueda H,Okamoto K,et al.TIMP1 promotes cell proliferation and invasion capability of right-sided colon cancers via the FAK/Akt signaling pathway[J].Cancer Sci,2022,113(12):4244-4257.
[6] 中华人民共和国卫生和计划生育委员会医政医管局.原发性肝癌诊疗规范(2017年版)[J].中华消化外科杂志,2017,16(7):635-647.
[7] 金 涛,何前进,毛伟明,等.原发性肝癌患者癌旁组织中GP73、GPC3蛋白表达及意义[J].山东医药,2018,58(26):41-43.
[8] Tian C,Li X,Ge C.High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma:A comprehensive TCGA analysis[J].Mol Med,2021,27(1):62-78.
[9] Chen YJ,Chang JT,You GR,et al.Panel biomarkers associated with cancer invasion and prognostic prediction for head-neck cancer[J].Biomark Med,2021,15(11):861-877.
[10] Walter V,Degraff DJ,Yamashita H.Characterization of laminin-332 gene expression in molecular subtypes of human bladder cancer[J].Am J Clin Exp Urol,2022,10(5):311-319.
[11] 李 晨,宋洪亮,俞海波,等.LAMA3在胰腺癌中的表达及其临床意义[J].肝胆胰外科杂志,2021,33(2):85-88,95.
[12] Feng LY,Huang YZ,Zhang W,et al.LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer[J].J Ovarian Res,2021,14(1):67.
[13] Xu SF,Zheng Y,Zhang L,et al.Long non-coding RNA LINC00628 interacts epigenetically with the LAMA3 promoter and contributes to lung adenocarcinoma[J].Mol Ther Nucleic Acids,2019,18:166-182.
[14] 徐建立,孙艳华,李 明,等.紫草素通过抑制上皮间质转化缓解结肠癌细胞5-氟尿嘧啶耐药[J].陕西中医,2022,43(3):296-300.
[15] Pang XJ,Liu XJ,Liu Y,et al.Drug discovery targeting focal adhesion kinase(FAK)as a promising cancer therapy[J].Molecules,2021,26(14):4250-4286.
[16] 李亚明,张智峰,刘 霞.华蟾素联合阿霉素对脑胶质瘤细胞增殖、体外侵袭能力的影响及机制研究[J].陕西医学杂志,2022,51(2):145-150.
[17] Kim H,Son S,Ko Y,et al.CTGF regulates cell proliferation,migration,and glucose metabolism through activation of FAK signaling in triple-negative breast cancer[J].Oncogene,2021,40(15):2667-2681.
[18] 阿力亚,胡文杰,彭宝岗,等.黏着斑激酶表达下调对肝癌细胞黏附迁移侵袭行为的影响[J].中华普通外科学文献:电子版,2016,10(2):93-98.
[19] 姚红兵,肖 芳,郭 威,等.FAK抑制剂对肝癌HCC-LM3细胞骨架重排和侵袭的作用机制[J].中山大学学报:医学科学版,2021,42(3):364-372.
[20] 王维杰,赵森峰,曹家辉,等.LAMA3在胰腺癌中的预后价值及机制的生物信息学分析[J].肝胆胰外科杂志,2021,33(9):533-538.
[21] 任 可,姚 楠,陆 军,等.黏着斑激酶在骨肉瘤中的表达及临床意义[J].中国肿瘤临床,2017,44(10):474-482.

相似文献/References:

[1]郭俊霞,魏晓华.乙肝肝硬化患者合并原发性肝癌的危险因素及预后分析*[J].陕西医学杂志,2019,(7):850.
[2]李 珣,张祥林.肝动脉化疗栓塞联合恩替卡韦对原发性肝癌治疗效果及对患者血清中恶性肿瘤特异性生长因子的影响[J].陕西医学杂志,2019,(7):873.
　LI Xun,ZHANG Xianglin..Efficacy observation and TSGF change in primary hepatocellular carcinoma by TACE and entecavir[J].,2019,(9):873.
[3]陶 琳.原发性肝癌患者化疗后抗菌药物的应用及继发感染的危险因素分析[J].陕西医学杂志,2023,52(1):89.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.021]
　TAO Lin.Application of antibiotics and risk factors of secondary infection in patients with primary liver cancer after chemotherapy[J].,2023,52(9):89.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.021]
[4]刘贤国,徐红玉,朱 江.原发性肝癌伴门静脉癌栓产生机制及经导管肝动脉化疗栓塞术联合其他介入方案治疗研究进展[J].陕西医学杂志,2023,52(10):1438.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.036]
　LIU Xianguo,XU Hongyu,ZHU Jiang.Research progress on mechanism of thrombus formation of primary liver cancer with portal vein cancer and application progress of TACE combined with other interventional protocols[J].,2023,52(9):1438.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.036]
[5]李晓勤,王 群,何晓兰,等.多模式镇痛对原发性肝癌患者休斯顿疼痛情况调查表评分及血清结合珠蛋白水平的影响[J].陕西医学杂志,2024,(4):475.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.008]
　LI Xiaoqin,WANG Qun,HE Xiaolan,et al.InfLuences of multimodal analgesia on HPOI score and serum haptoglobin level in patients with hepatocellular carcinoma[J].,2024,(9):475.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.008]
[6]孟凡岗,刘文宇,甄立军,等.原发性肝癌组织长链非编码RNA JPX、微小RNA-371a-5p表达水平及其与患者术后5年预后关系研究[J].陕西医学杂志,2024,(8):1130.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.027]
　MENG Fangang,LIU Wenyu,ZHEN Lijun,et al.Expression levels of long non-coding RNA JPX and microRNA-371a-5p in primary liver cancer tissues and their relationship with 5-year prognosis of patients after surgery[J].,2024,(9):1130.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.027]

备注/Memo

备注/Memo:
基金项目:河北省医学科学研究课题(20221840)
更新日期/Last Update: 2023-09-04